Meeting Oligo Synthesis Demands with Increased Capacity and Tailored Packaging Solutions
To ensure continued supply security and accommodate global demand, emp Biotech (via its Campo Amargo subsidiary) recently opened a new 1,800 m² facility in the Bitterfeld-Wolfen Chemical Park. This site boosts production of oligonucleotide synthesis reagents used in DNA and RNA synthesis and adds capacity for future growth. With this expansion, customers can count on the … Read more








